Riskpilot← Back to searchSign inGet full accessMedbroker ApS
APSActiveCVR 31892236Hovedgaden 20Research and experimental development on natural sciences and engineering · NACE 7210Est. 20093 employees
Revenue 2024
DKK -144K
+119% vs 2023
EBITDA margin
100.9%
-11% vs 2023
Equity ratio
37.1%
Financial strength
Net profit 2024
DKK -407K
0% vs 2023
| Revenue | DKK -144K | +119% |
| EBITDA | DKK -145K | -11% |
| Net profit | DKK -407K | +0% |
| Total assets | DKK 307K | -53% |
| Equity | DKK 114K | -78% |
| Employees | 3 | — |
Legal name
Medbroker ApS
CVR number
31892236
Legal form
Anpartsselskab
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
2. januar 2009
Share capital
DKK 703.800
Employees
3 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af selskabets administrerende direktør
Company purpose
Selskabets formål er at udvikle, producere og sælge medicinsk udstyr og dermed beslægtet virksomhed.
Address
Hovedgaden 20
Phone
+4522143822
Email
ceo@medbroker.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -33 | 5 | -23 | -56 | 400 | 19 | 515 | 1.109 | 646 | 130 | -57 | -66 | -144 |
| Staff expenses | -0 | -61 | -0 | -41 | -69 | -15 | -117 | -660 | -657 | -297 | -76 | -65 | -1 |
| EBITDA | -33 | -57 | -23 | -96 | 331 | 4 | 398 | 449 | -11 | -168 | -132 | -131 | -145 |
| Depreciation & amort. | -1.525 | -7 | -4 | -12 | -27 | -124 | -150 | -178 | -257 | -220 | -220 | -271 | -254 |
| EBIT | -1.558 | -63 | -27 | -109 | 304 | -120 | 248 | 271 | -268 | -388 | -352 | -402 | -399 |
| Net financials | 0 | -0 | 1 | -0 | 0 | -0 | -7 | -5 | -2 | 2 | 3 | -3 | -8 |
| Profit before tax | -1.558 | -63 | -26 | -109 | 305 | -120 | 241 | 266 | -270 | -386 | -349 | -405 | -407 |
| Tax | -14 | -14 | -0 | -26 | -0 | -8 | -6 | -0 | -89 | -42 | -14 | -0 | -0 |
| Net profit | -1.544 | -50 | -26 | -83 | 305 | -112 | 247 | 266 | -182 | -343 | -335 | -405 | -407 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 222 | 149 | 114 | 1.159 | 1.481 | 1.634 | 1.785 | 2.043 | 1.778 | 1.386 | 1.071 | 656 | 307 |
| Equity | 172 | 122 | 96 | 1.112 | 1.417 | 1.305 | 1.552 | 1.818 | 1.636 | 1.260 | 925 | 520 | 114 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 67 | 63 | 66 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 51 | 27 | 19 | 46 | 65 | 262 | 169 | 159 | 142 | 125 | 145 | 136 | 193 |
| Total debt | 51 | 27 | 19 | 46 | 65 | 329 | 233 | 225 | 142 | 125 | 145 | 136 | 193 |
EBITDA margin
-14548800.0%
This company
15.8%
Market median
-92081113% vs market
20122024
Equity ratio
37.1%
This company
38.2%
Market median
+3% vs market
20122024
Return on equity
-357.9%
This company
18.4%
Market median
-2045% vs market
20122024
Net profit margin
-40676000.0%
This company
8.1%
Market median
-502172940% vs market
20122024
Asset turnover
-0.47×
This company
1.12×
Market median
-142% vs market
20122024
Debt / equity
1.70×
This company
0.62×
Market median
-174% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2011 | — | — | |
| Board of Directors | 2009 | — | — | |
| Chairman | 2011 | — | — | |
| Chairman | 2009 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
MEDBROKER INVEST ApS | Company | 100.0% | 100.0% | 2015 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
MEDBROKER INVEST ApS
Medbroker ApS Board members of Medbroker ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jon Ingi Benediktsson | Chairman | 0 companies |
| Line Holten Reimer | Board of Directors | 0 companies |
| Henrik Carlheim Dørge | Chairman | 0 companies |
| Bjarne Bo Jensen | Chairman | 0 companies |